Nazila Habibizad - 01 Oct 2022 Form 4 Insider Report for Global Blood Therapeutics, Inc.

Role
Executive Vice President, Operations
Signature
/s/ Miguel Carrillo, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Oct 2022
Net transactions value
$0
Form type
4
Filing time
04 Oct 2022, 17:00:23 UTC
Previous filing
29 Sep 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GBT Common Stock Gift $0 -3,500 -8.4% $0.000000 38,123 29 Sep 2022 Direct
transaction GBT Common Stock Options Exercise +1,375 +3.6% 39,498 01 Oct 2022 Direct F1
transaction GBT Common Stock Options Exercise +182 +0.46% 39,680 01 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GBT Restricted Stock Units Options Exercise $0 -1,375 -33% $0.000000 2,750 01 Oct 2022 Common Stock 1,375 Direct F1, F2
transaction GBT Restricted Stock Units Options Exercise $0 -182 -25% $0.000000 548 01 Oct 2022 Common Stock 182 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2 The shares of Common Stock underlying the original grant of 11,000 RSUs vest in eight semi-annual installments after October 1, 2019 through October 1, 2023, subject to the Reporting Person's continuous service with the Issuer through each vesting date, and have no expiration date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
F3 The shares of Common Stock underlying the original grant of 1,461 RSUs vest in eight semi-annual installments after April 1, 2020 through April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each vesting date, and have no expiration date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.

Remarks:

Executive Vice President, Operations